MY8300240A - Medicamens for treating hypertension - Google Patents

Medicamens for treating hypertension

Info

Publication number
MY8300240A
MY8300240A MY240/83A MY8300240A MY8300240A MY 8300240 A MY8300240 A MY 8300240A MY 240/83 A MY240/83 A MY 240/83A MY 8300240 A MY8300240 A MY 8300240A MY 8300240 A MY8300240 A MY 8300240A
Authority
MY
Malaysia
Prior art keywords
medicamens
treating hypertension
hypertension
treating
Prior art date
Application number
MY240/83A
Other languages
English (en)
Inventor
Zola P Horovitz
Bernard Rubin
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY8300240(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of MY8300240A publication Critical patent/MY8300240A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MY240/83A 1977-12-27 1983-12-30 Medicamens for treating hypertension MY8300240A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27

Publications (1)

Publication Number Publication Date
MY8300240A true MY8300240A (en) 1983-12-31

Family

ID=25343256

Family Applications (2)

Application Number Title Priority Date Filing Date
MY240/83A MY8300240A (en) 1977-12-27 1983-12-30 Medicamens for treating hypertension
MYPI87003001A MY102991A (en) 1977-12-27 1987-10-31 Medicaments for treating hypertension.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MYPI87003001A MY102991A (en) 1977-12-27 1987-10-31 Medicaments for treating hypertension.

Country Status (30)

Country Link
JP (1) JPS54110333A (sv)
AR (1) AR230378A1 (sv)
AU (1) AU526239B2 (sv)
BE (1) BE873092A (sv)
CA (1) CA1120400A (sv)
CH (1) CH642542A5 (sv)
DE (1) DE2854316C3 (sv)
DK (1) DK578778A (sv)
EG (1) EG14178A (sv)
FI (1) FI783991A (sv)
FR (1) FR2413089A1 (sv)
GB (1) GB2010675B (sv)
GR (1) GR72951B (sv)
HK (1) HK45483A (sv)
HU (1) HU178747B (sv)
IE (1) IE48306B1 (sv)
IL (1) IL56281A (sv)
IT (1) IT1202811B (sv)
KE (1) KE3235A (sv)
LU (1) LU80709A1 (sv)
MY (2) MY8300240A (sv)
NL (2) NL192870C (sv)
NO (1) NO784357L (sv)
NZ (1) NZ189159A (sv)
PH (1) PH22111A (sv)
PL (1) PL212188A1 (sv)
PT (1) PT68983A (sv)
SE (1) SE445173B (sv)
SG (1) SG41482G (sv)
ZA (1) ZA786948B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
PH22111A (en) 1988-06-01
AR230378A1 (es) 1984-04-30
CA1120400A (en) 1982-03-23
NZ189159A (en) 1984-12-14
GB2010675A (en) 1979-07-04
NL980017I1 (nl) 1998-07-01
IE782413L (en) 1979-06-27
AU4204178A (en) 1979-07-05
IT7831266A0 (it) 1978-12-22
NL7812164A (nl) 1979-06-29
IE48306B1 (en) 1984-12-12
PT68983A (en) 1979-01-01
IL56281A (en) 1983-05-15
KE3235A (en) 1982-11-05
NL192870C (nl) 1998-04-02
AU526239B2 (en) 1982-12-23
DE2854316A1 (de) 1979-07-05
GR72951B (sv) 1984-01-17
NL192870B (nl) 1997-12-01
CH642542A5 (de) 1984-04-30
ZA786948B (en) 1980-04-30
HU178747B (en) 1982-06-28
FI783991A (fi) 1979-06-28
DK578778A (da) 1979-06-28
JPS54110333A (en) 1979-08-29
SE7813277L (sv) 1979-06-28
EG14178A (en) 1984-06-30
DE2854316C3 (de) 1994-12-22
BE873092A (fr) 1979-06-27
IL56281A0 (en) 1979-03-12
SE445173B (sv) 1986-06-09
GB2010675B (en) 1982-06-16
NO784357L (no) 1979-06-28
HK45483A (en) 1983-10-28
SG41482G (en) 1985-01-11
LU80709A1 (de) 1979-04-13
FR2413089B1 (sv) 1980-12-26
PL212188A1 (sv) 1980-02-11
IT1202811B (it) 1989-02-09
MY102991A (en) 1993-03-31
FR2413089A1 (fr) 1979-07-27
DE2854316C2 (sv) 1989-08-10
JPS647045B2 (sv) 1989-02-07

Similar Documents

Publication Publication Date Title
JPS53146427A (en) Set for construction
JPS5317572A (en) Improvement for treating substances
JPS5463549A (en) Device for treating sewage
GB2004613B (en) Camshaft
YU203378A (en) Hollow-brick block
JPS53113380A (en) Chuck
MY8300240A (en) Medicamens for treating hypertension
IL51429A (en) Coccidiocidal composition for treating
GB1557345A (en) Chuck
JPS5479235A (en) Coal treating method
JPS53121939A (en) Novel treating composition
ZA782640B (en) Pivotal auxiliary roof-support
GB1554602A (en) Isulated chips
GB2003475B (en) Process for 2-chlorosulphinylazetidin-4-ones
JPS5424627A (en) Removinggagent for phtoresist
JPS5482417A (en) Paper treating method
JPS53127835A (en) Treating agent for burn
JPS5413465A (en) Twoostage treatment for effluent
JPS5411035A (en) Sprayy type treating method
GB2002231B (en) Hypertension treating agent
JPS5416489A (en) Antidyeing treatment
JPS5433362A (en) Device for treating sewage
JPS54163826A (en) Hypertension treating agent
JPS5449348A (en) Set for *inarizushi*
JPS53116362A (en) Process for 16alphaamethylsteroid